Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22159,168,1.30 [0.93-1.81],0.121096772194227
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23159,185,0.95 [0.67-1.34],0.7536562305014429
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22920,1374,1.04 [0.92-1.18],0.5016644324996208
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Candidiasis,23172,364,0.92 [0.71-1.17],0.482051220092122
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22495,3384,1.03 [0.95-1.11],0.5109044378203675
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22461,3400,1.02 [0.95-1.11],0.5646840463801968
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22962,1025,1.04 [0.90-1.20],0.622345230736586
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23097,81,1.06 [0.64-1.77],0.8142104590274414
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20999,1081,1.08 [0.94-1.25],0.2695375886808698
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20265,1200,1.11 [0.97-1.27],0.1132480792118157
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,20000,241,0.97 [0.71-1.32],0.8506646190516686
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16295,2210,1.02 [0.92-1.13],0.6897635368496082
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,19930,394,1.14 [0.90-1.43],0.2781023800509931
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23159,1222,1.01 [0.88-1.15],0.904641485869529
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Mycoses,23259,451,0.95 [0.76-1.18],0.6483616033774284
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22418,872,1.12 [0.97-1.31],0.1282734270557085
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23183,1192,1.13 [0.99-1.28],0.0763479101797005
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22124,187,0.95 [0.68-1.34],0.7782128435298533
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23297,50,0.72 [0.36-1.43],0.3422569595303795
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23033,1042,1.09 [0.94-1.25],0.248994497873305
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23083,67,1.08 [0.62-1.87],0.7863556427943376
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23240,117,1.28 [0.87-1.90],0.2126646079004837
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23220,97,1.44 [0.95-2.18],0.0820081880329103
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22020,474,0.95 [0.77-1.18],0.6368495514689156
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,21825,279,0.97 [0.73-1.28],0.8226407083525444
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22024,87,0.99 [0.60-1.62],0.9534072207004316
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23278,68,1.56 [0.97-2.49],0.0659670052108766
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23241,141,1.04 [0.70-1.53],0.8547332499573259
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral warts,23152,52,1.30 [0.72-2.35],0.3781888133910817
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23150,50,0.68 [0.34-1.37],0.2846995155213844
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm,22987,333,0.91 [0.70-1.18],0.4820605494945718
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23228,46,0.60 [0.29-1.25],0.173998966364645
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23193,51,1.23 [0.67-2.27],0.5082965716750942
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23250,128,1.20 [0.81-1.77],0.3618078744996923
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22936,1597,0.91 [0.81-1.02],0.1036000210499143
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of meninges,23298,32,1.39 [0.67-2.89],0.3701130957252648
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23234,63,1.14 [0.64-2.03],0.6624145740682356
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23283,76,0.97 [0.57-1.64],0.9016599296327714
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23273,431,0.81 [0.65-1.03],0.0810055566862014
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Caecum,23267,336,0.75 [0.58-0.98],0.0368105715709022
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23174,81,1.03 [0.62-1.72],0.9089877903189594
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Descending colon,23265,270,0.90 [0.68-1.20],0.4663675591370685
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Rectum,23227,410,0.91 [0.72-1.15],0.4445249488199533
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23174,706,0.82 [0.69-0.99],0.0340140424096514
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23254,542,0.87 [0.71-1.07],0.1978175803830628
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",18109,70,1.25 [0.74-2.12],0.4065747953652927
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",18106,67,1.14 [0.65-2.00],0.6565572519643961
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23266,96,1.07 [0.68-1.71],0.7608246665629502
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Haemangioma, any site",23266,93,1.09 [0.68-1.75],0.7162177626492598
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Lung cancer and mesothelioma,15512,337,1.26 [0.98-1.62],0.0656961966154152
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Lymphoid leukaemia,18103,64,1.22 [0.69-2.15],0.4927475217968181
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",18233,194,1.22 [0.88-1.68],0.226879075948917
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",18323,284,0.84 [0.63-1.12],0.2217768763006019
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",18125,86,0.78 [0.46-1.33],0.3615475964229656
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",18178,139,1.31 [0.90-1.90],0.162062525711032
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",18177,138,0.61 [0.40-0.94],0.0258123425796768
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",18119,80,0.80 [0.46-1.39],0.4309942770631002
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19406,1367,1.01 [0.89-1.14],0.901915292193102
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",18182,143,0.92 [0.62-1.38],0.6866611508121157
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",18141,102,0.78 [0.48-1.26],0.3051342253076088
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,18163,124,1.11 [0.73-1.69],0.616044939094925
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Melanocytic naevi,23173,164,1.14 [0.81-1.61],0.4476801838350016
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Melanocytic naevi of trunk,23265,90,1.10 [0.69-1.76],0.689565705622591
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Melanoma in situ,18071,70,0.91 [0.51-1.64],0.7625097628143772
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",18134,95,1.22 [0.77-1.94],0.3922008093359466
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",18197,158,1.34 [0.95-1.88],0.0977744427808395
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",18254,215,1.18 [0.86-1.62],0.3132271434054885
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",18135,96,1.20 [0.76-1.90],0.4250428049369132
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Other benign neoplasms of skin,23168,133,1.11 [0.76-1.64],0.5872844539129456
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19211,1172,0.97 [0.85-1.12],0.6799180598719543
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19283,1244,0.98 [0.86-1.12],0.7528585058618145
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23027,299,0.83 [0.63-1.10],0.1916216490092169
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21620,115,1.24 [0.82-1.88],0.3036836847154495
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22798,70,0.94 [0.53-1.64],0.8188844307421076
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22760,2712,0.92 [0.84-1.00],0.0547234151150543
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22052,60,0.87 [0.47-1.60],0.6500949622520582
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22891,52,1.01 [0.53-1.92],0.9770551940117418
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22934,1429,0.89 [0.79-1.01],0.0759642425318352
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22932,1427,0.89 [0.79-1.01],0.0772306937158782
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21605,100,0.94 [0.58-1.50],0.7870067350615788
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23066,1074,0.96 [0.83-1.11],0.5788820116275573
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22940,101,1.19 [0.77-1.84],0.4415173017928663
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22804,76,1.44 [0.91-2.29],0.1210988428755681
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22789,61,0.51 [0.26-0.98],0.0424667082172912
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23142,303,1.04 [0.80-1.35],0.7621677146945471
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23205,49,1.23 [0.67-2.26],0.5106970261482568
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23083,244,0.98 [0.73-1.32],0.8811742406450027
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22068,76,0.71 [0.41-1.25],0.2345396635992838
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,17188,372,1.07 [0.85-1.36],0.5646863303708629
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21304,164,0.67 [0.45-0.99],0.0445564242298596
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21326,186,0.94 [0.67-1.33],0.7290483658322996
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,16873,57,1.09 [0.60-2.00],0.771313161309629
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21952,63,0.63 [0.34-1.19],0.1550648318549636
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21206,215,1.01 [0.74-1.39],0.940813788909896
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",22802,600,1.04 [0.86-1.25],0.713123880018599
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22443,241,1.18 [0.88-1.58],0.2643217984236099
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22365,163,0.88 [0.60-1.28],0.4970423740630029
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23002,1113,0.93 [0.81-1.07],0.292259273571196
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19936,1072,0.94 [0.81-1.08],0.3565199932329723
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",16885,69,1.28 [0.77-2.11],0.3432797912515549
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22430,38,0.55 [0.24-1.25],0.1524138858034145
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,17089,273,1.09 [0.83-1.44],0.5365961141683965
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,16884,68,1.81 [1.19-2.76],0.0055269989696479
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,20591,3775,1.00 [0.93-1.08],0.9385361336821896
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,16998,182,1.11 [0.80-1.56],0.5242155816830443
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,17374,558,1.11 [0.92-1.34],0.2832034766010604
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23242,275,1.07 [0.81-1.41],0.63314391631964
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23059,92,1.28 [0.82-2.00],0.2865037937279792
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,16965,149,1.07 [0.74-1.55],0.7250658354428001
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",16881,65,0.90 [0.51-1.61],0.7308215213156459
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23123,731,1.00 [0.85-1.19],0.9717916931997332
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,17117,301,1.31 [1.02-1.68],0.0323607006195079
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,17187,371,0.99 [0.78-1.26],0.9296282752963012
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",17532,716,0.91 [0.76-1.09],0.3039780045127857
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,16957,141,0.97 [0.66-1.44],0.8943573658357906
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23052,85,1.32 [0.84-2.10],0.2325251333172068
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,17376,560,0.91 [0.74-1.11],0.336620177876817
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,17200,384,0.90 [0.70-1.14],0.3792451665745834
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21058,67,1.47 [0.90-2.40],0.1223731764186573
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21879,5063,1.00 [0.94-1.07],0.9220908792435852
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22412,20,1.22 [0.46-3.25],0.6836407354218291
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22414,22,0.57 [0.20-1.64],0.293972144781407
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23130,1739,0.91 [0.81-1.01],0.0897614177586917
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23127,1735,0.91 [0.81-1.01],0.0874884204194225
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22414,22,1.02 [0.39-2.71],0.9620789273095632
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23029,786,0.97 [0.82-1.14],0.6817178794978003
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18410,1594,1.03 [0.91-1.15],0.6568378293967689
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23287,257,1.11 [0.84-1.46],0.4610241436468177
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22307,105,1.42 [0.94-2.14],0.0985199251264008
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22317,74,0.80 [0.46-1.40],0.4325336444648732
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22326,83,0.87 [0.52-1.46],0.5875701832253127
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",16877,61,1.03 [0.58-1.84],0.924103868568278
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20563,160,1.00 [0.70-1.44],0.9847139573389354
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2451,119,1.00 [0.66-1.51],0.9866608564048106
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2616,315,0.79 [0.61-1.03],0.0806443846335675
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20501,98,1.11 [0.72-1.72],0.6407985273193905
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2411,81,1.09 [0.66-1.78],0.7462125892185387
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22530,2127,1.13 [1.03-1.25],0.0089873923188953
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22556,354,1.02 [0.79-1.30],0.891597980539983
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21224,233,0.88 [0.65-1.20],0.41968019398662
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,17594,778,0.99 [0.84-1.17],0.9035311580087152
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23177,246,1.00 [0.74-1.34],0.9999157935121008
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22090,267,0.98 [0.73-1.30],0.8700127267334371
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Angina pectoris,20441,1473,1.03 [0.92-1.16],0.5983450715511219
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22199,376,1.07 [0.84-1.35],0.6004799765226405
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21904,81,0.88 [0.51-1.50],0.6311087316016519
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22065,242,0.96 [0.71-1.30],0.807621826942784
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,13638,2262,1.00 [0.90-1.10],0.9421883915238836
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,AV-block,18743,602,0.96 [0.79-1.16],0.6699459910283592
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23224,530,0.94 [0.77-1.15],0.5606875179255867
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Cardiac arrest,11624,248,1.08 [0.80-1.45],0.6204138676356228
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18340,199,1.15 [0.84-1.57],0.3781210913110082
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",18250,109,0.85 [0.54-1.35],0.4910051356516004
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23299,65,1.28 [0.74-2.23],0.376957357975787
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Conduction disorders,19464,1323,1.00 [0.88-1.13],0.980590548604945
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21524,2580,1.03 [0.94-1.13],0.4993478852816111
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,19605,7586,0.98 [0.93-1.04],0.5762008907355389
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22098,269,1.00 [0.76-1.33],0.986499478129116
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Endocarditis,18226,85,1.15 [0.71-1.86],0.5690137303055257
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22990,1287,1.08 [0.95-1.23],0.2233251956879991
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypertension,20785,6622,1.01 [0.95-1.07],0.8266221802107294
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Hypertension, essential",20809,6646,1.01 [0.95-1.07],0.8056619607990009
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23077,105,0.68 [0.42-1.11],0.122556697543795
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14344,181,1.17 [0.84-1.64],0.3571505082174089
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14328,165,1.13 [0.80-1.61],0.4877788429963171
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypotension,23154,1191,1.07 [0.94-1.22],0.3265047863433508
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22254,114,0.68 [0.43-1.09],0.1095256588047293
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21660,2692,1.02 [0.94-1.12],0.5862078968266018
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22879,636,0.99 [0.83-1.20],0.9513544183120805
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Left bundle-branch block,18550,409,1.16 [0.93-1.44],0.1935623921395354
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22580,1038,1.04 [0.90-1.20],0.6072004003406766
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19867,899,1.06 [0.91-1.23],0.4472100558395917
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23140,214,1.03 [0.75-1.42],0.8442343100091453
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23248,362,0.98 [0.77-1.25],0.8890374438386093
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Oesophageal varices,21895,66,1.12 [0.64-1.95],0.691609206418186
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other aneurysm,21918,95,0.84 [0.51-1.38],0.4843056817022712
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other arrhythmias,18615,474,0.98 [0.79-1.21],0.8467254910014993
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21954,131,0.89 [0.58-1.35],0.5751142617719054
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22096,273,0.84 [0.63-1.13],0.2543488547061622
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,18337,196,1.04 [0.75-1.44],0.8294285349850065
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other disorders of veins,21922,93,0.79 [0.48-1.30],0.3491411144068789
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,21875,46,1.34 [0.71-2.53],0.36567863811896
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,21746,86,0.67 [0.39-1.15],0.149560402891474
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21931,102,0.82 [0.51-1.31],0.4050250092142273
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,19359,1218,0.92 [0.80-1.05],0.2307716346668945
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22026,63,1.11 [0.62-1.97],0.7299082822017067
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22387,564,1.03 [0.85-1.26],0.7311768459725234
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22661,356,1.43 [1.14-1.78],0.0015919537379023
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22315,655,0.94 [0.78-1.13],0.4965173061593012
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,11745,369,0.97 [0.76-1.25],0.8388489361564485
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22298,522,1.01 [0.83-1.24],0.9210105165144972
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22176,347,0.97 [0.75-1.24],0.7888197440240549
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22794,489,1.02 [0.82-1.25],0.8889553474334245
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23235,697,0.95 [0.80-1.14],0.6002516125195934
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Right bundle-branch block,18601,460,1.07 [0.87-1.32],0.5186720527497196
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22659,354,1.43 [1.15-1.79],0.001476398375875
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,21875,215,0.87 [0.63-1.20],0.3947779135625763
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22863,723,0.94 [0.79-1.13],0.5274914143764643
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22848,747,0.94 [0.79-1.12],0.5077018838364453
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22234,42,0.56 [0.26-1.22],0.1456609968536474
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21936,114,0.77 [0.49-1.22],0.2733645666492126
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22482,239,1.11 [0.83-1.49],0.4783444825540638
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21852,310,0.99 [0.76-1.28],0.9177013732221112
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Varicose veins,22205,376,0.74 [0.57-0.95],0.0173579891924338
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,21842,75,1.14 [0.68-1.91],0.6284930818961028
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23062,765,0.99 [0.84-1.18],0.9439857688604242
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23103,488,0.88 [0.71-1.10],0.2614566002300821
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20027,953,0.95 [0.82-1.10],0.4987346964015843
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Any mental disorder,22631,3557,0.99 [0.92-1.07],0.7835858991428573
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23044,579,0.89 [0.73-1.09],0.2533032042150142
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20223,1149,0.92 [0.80-1.06],0.2592823272758162
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19157,83,1.29 [0.82-2.06],0.2742220158446952
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Smoking dependency,22670,1495,1.07 [0.95-1.21],0.2423171887364005
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20906,1832,1.01 [0.91-1.13],0.8141831264460355
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Vascular dementia,22794,148,0.79 [0.53-1.18],0.2541019089351869
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Alzheimer disease,23296,298,1.19 [0.92-1.54],0.1923472628799222
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",15475,57,0.98 [0.52-1.85],0.9514082019084384
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Bell's palsy,21953,74,0.67 [0.38-1.19],0.1733399842814765
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22212,333,0.85 [0.65-1.10],0.2131698895652247
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Cerebral cysts,22906,229,0.79 [0.57-1.09],0.148761203303787
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23214,354,0.81 [0.62-1.04],0.1033112168919707
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,22798,59,1.16 [0.65-2.07],0.6228904180752963
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23278,72,1.06 [0.62-1.81],0.8299248371518418
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22765,88,1.01 [0.61-1.66],0.9794345485407868
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Epilepsy,21710,281,0.77 [0.57-1.03],0.0736523715808143
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22767,1338,0.85 [0.75-0.97],0.0155612573523679
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23262,674,0.91 [0.76-1.09],0.3066225069757385
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22762,2165,0.84 [0.76-0.93],0.0011579945894483
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Generalized epilepsy,22916,59,0.99 [0.54-1.82],0.967824546791378
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Hemiplegia,23132,272,0.80 [0.60-1.07],0.138897092411802
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Hydrocephalus,22731,54,0.90 [0.47-1.71],0.7445450135937262
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23279,60,1.54 [0.91-2.58],0.1048605245323991
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21899,20,2.01 [0.91-4.44],0.0842900787052567
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21972,93,1.51 [1.00-2.29],0.0504474675705414
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Memory loss,22634,118,0.88 [0.57-1.37],0.5823500730715679
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Migraine,21623,194,0.80 [0.56-1.13],0.2025440712932318
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23273,175,0.81 [0.56-1.17],0.2657179928153508
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Motor neuron disease,15581,150,1.00 [0.69-1.47],0.9913673356245768
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23189,62,1.08 [0.60-1.93],0.7954907525638585
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22833,954,0.94 [0.81-1.09],0.4195591279601222
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Neurological diseases,22007,3598,0.93 [0.86-1.01],0.0726983419292803
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22970,231,0.82 [0.60-1.13],0.2284394167765476
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22263,384,0.88 [0.69-1.13],0.3177588604398902
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23209,344,1.16 [0.92-1.47],0.2110533742116788
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18261,611,1.00 [0.83-1.21],0.997648510463046
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22755,78,0.93 [0.55-1.58],0.7934350372842267
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22824,147,0.70 [0.46-1.04],0.0802307462924446
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22724,136,1.00 [0.67-1.49],0.9996085253014816
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21970,91,0.69 [0.41-1.15],0.1506820359352645
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other headache syndromes,21467,38,0.44 [0.19-1.01],0.0527192949372394
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other neurological diseases,23184,507,0.89 [0.72-1.10],0.2916516487311752
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other sleep disorders,22124,695,0.87 [0.72-1.03],0.110082832176452
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Parkinson's disease,23276,531,0.84 [0.68-1.04],0.1107411975988299
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22703,26,0.49 [0.18-1.35],0.1675840799057925
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Restless leg syndrome,23297,48,1.35 [0.72-2.54],0.3449568352742173
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Sleep apnoea,22996,626,0.93 [0.77-1.12],0.4311818852692336
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Small fibre neuropathy,22919,54,0.93 [0.49-1.76],0.8195568102114674
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23281,173,1.07 [0.76-1.52],0.6965261704162183
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21913,34,0.71 [0.30-1.65],0.4220206707384111
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23296,301,1.19 [0.92-1.54],0.1953864569697093
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22763,144,0.82 [0.55-1.23],0.3372356600054957
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22764,86,1.13 [0.70-1.84],0.6142676852834319
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22960,288,0.73 [0.54-0.97],0.0310689254790966
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23100,290,0.97 [0.74-1.26],0.8007276153982961
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22446,42,1.05 [0.52-2.12],0.89405055160318
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22465,61,1.98 [1.30-3.03],0.0015194364086554
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23206,45,1.27 [0.67-2.39],0.4591704486990975
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23067,121,0.64 [0.41-1.01],0.0565207670286695
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2415,83,1.06 [0.65-1.74],0.8083234088690545
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2944,126,1.05 [0.70-1.57],0.8055492533633493
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22771,93,0.78 [0.47-1.28],0.3195966302473499
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23057,971,0.88 [0.75-1.02],0.0894034163818224
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23001,597,0.99 [0.82-1.20],0.9289309514241016
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22547,143,1.08 [0.74-1.57],0.6939758332928153
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23225,553,0.79 [0.64-0.97],0.0235117799785702
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23294,65,1.25 [0.74-2.14],0.4049339114233655
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23157,485,0.79 [0.63-0.98],0.0328159973061701
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23258,312,0.81 [0.62-1.07],0.1403338415484346
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23208,146,1.09 [0.75-1.58],0.6594631543527827
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22480,76,1.18 [0.71-1.98],0.5183056603018872
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22485,81,0.95 [0.56-1.61],0.8517862264816557
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22446,42,1.26 [0.65-2.45],0.4939579258691207
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23203,667,0.96 [0.80-1.15],0.6235801384701243
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22714,178,1.17 [0.84-1.62],0.3540114140706805
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22702,30,1.65 [0.83-3.27],0.152443127434792
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23039,93,0.89 [0.55-1.46],0.6506359531975776
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23171,225,0.78 [0.56-1.07],0.1247138249181372
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22836,164,0.83 [0.57-1.21],0.3369970515077808
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23145,83,0.94 [0.56-1.57],0.8110830870819762
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22989,453,0.93 [0.74-1.16],0.5045069787915963
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22801,123,1.03 [0.68-1.55],0.8936233659307813
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,21954,1750,1.04 [0.93-1.16],0.5070040310073488
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23140,194,0.76 [0.54-1.08],0.1306081524660618
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23284,142,0.90 [0.61-1.34],0.6076605667218794
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22804,400,0.93 [0.74-1.18],0.5663113645674804
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23008,62,0.73 [0.39-1.37],0.3305686448134295
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23283,54,1.23 [0.68-2.22],0.4860670321303724
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22477,73,1.13 [0.67-1.92],0.648061776124836
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22536,132,0.59 [0.38-0.92],0.0188705871840146
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22210,124,1.13 [0.76-1.69],0.5422596365679109
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22724,52,0.91 [0.47-1.76],0.7823066365011005
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22147,61,0.97 [0.53-1.78],0.9133695473204174
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22586,50,0.92 [0.47-1.79],0.7970423897472001
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22739,203,0.99 [0.71-1.37],0.9370280985355656
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22519,115,1.10 [0.72-1.67],0.6523335228094518
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22207,121,0.56 [0.35-0.89],0.0136200162299158
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22176,90,0.96 [0.59-1.58],0.8832162404188935
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21644,1440,0.88 [0.78-0.99],0.0409916858424656
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22461,57,0.88 [0.46-1.65],0.6800880449748823
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23058,380,0.98 [0.77-1.25],0.8780281540191895
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22746,68,1.05 [0.61-1.83],0.8513073935868223
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22843,165,0.98 [0.69-1.41],0.9325086270385076
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23123,54,1.11 [0.60-2.03],0.7426815314732034
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23256,119,0.49 [0.31-0.78],0.0028856063162699
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23171,112,0.68 [0.42-1.09],0.107667441054746
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23117,48,1.28 [0.69-2.36],0.438743782706843
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,23122,53,1.47 [0.85-2.55],0.172094309850905
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23203,953,0.90 [0.77-1.05],0.1771490021518059
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22956,706,0.93 [0.78-1.11],0.4413286204429082
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22376,126,0.80 [0.52-1.22],0.296742985765885
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22333,83,0.84 [0.49-1.42],0.5157855420552568
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Acute pharyngitis,23093,59,1.25 [0.72-2.19],0.4310097989344871
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23215,181,0.97 [0.69-1.37],0.8718230623831871
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23092,58,0.89 [0.48-1.66],0.714854825292373
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,All influenza,21066,105,1.66 [1.13-2.44],0.0098433112968383
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),21063,102,1.67 [1.13-2.47],0.009592104835143
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Allergic asthma (mode),15277,102,0.99 [0.63-1.56],0.9659906276167912
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Allergic rhinitis,23191,264,0.96 [0.72-1.27],0.755675867181002
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",16242,1398,0.91 [0.81-1.04],0.1648973382025716
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16547,1372,0.92 [0.81-1.05],0.2097940620564754
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22921,146,1.23 [0.86-1.77],0.2622494147503943
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",21055,94,1.22 [0.78-1.91],0.3935405616724722
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Bronchiectasis,20256,284,1.20 [0.93-1.56],0.1603401098394314
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20015,43,1.33 [0.70-2.56],0.3856902117324128
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22462,2490,0.99 [0.90-1.09],0.8734544158997788
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",21874,75,0.92 [0.54-1.59],0.7755359676751994
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Chronic sinusitis,21955,156,1.17 [0.82-1.67],0.3792935241751607
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23076,1275,1.00 [0.88-1.14],0.98440535747614
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Deviated nasal septum,21935,136,1.06 [0.72-1.57],0.7557765751991439
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21323,5150,1.00 [0.93-1.06],0.8838217461996061
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22180,381,1.00 [0.79-1.27],0.9903021018573456
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Early onset COPD,22101,300,1.39 [1.09-1.77],0.0072005619294281
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Emphysema,20311,339,1.22 [0.96-1.55],0.1109320391482121
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22392,329,1.34 [1.06-1.70],0.0141543329359302
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23059,2098,1.06 [0.96-1.18],0.2214595248644339
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Interstitial lung disease,22419,356,1.29 [1.03-1.63],0.027642123446343
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Later onset COPD,22254,975,0.86 [0.73-1.00],0.0512710934592108
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23279,420,1.09 [0.87-1.36],0.4642470996251455
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Nasal polyp,21935,136,1.20 [0.82-1.76],0.3400588490296085
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23028,980,1.25 [1.08-1.43],0.0024578836441268
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other diseases of pleura,23016,2145,1.02 [0.92-1.12],0.742825760806503
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22650,851,0.94 [0.80-1.11],0.4655242714883639
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other pleural conditions,20934,63,0.88 [0.48-1.60],0.6675774856747791
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23200,431,1.27 [1.03-1.56],0.0258433662614148
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23174,1358,0.95 [0.84-1.08],0.4592310629332854
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pleural effusion,21978,1107,1.09 [0.95-1.25],0.2062480588552302
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pleural plaque,21130,259,1.12 [0.84-1.48],0.4330858851786245
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22798,1837,1.06 [0.95-1.18],0.2902001638038958
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23179,320,1.13 [0.88-1.46],0.3477985070020075
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pneumothorax,21011,140,1.17 [0.80-1.71],0.4097080434483107
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pollen allergy,23283,231,0.93 [0.68-1.26],0.6366734302983013
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pulmonary oedema,22831,62,1.56 [0.94-2.61],0.0877275709592533
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Respiratory insufficiency,15231,56,1.55 [0.90-2.67],0.1105211593511028
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23010,962,1.24 [1.07-1.43],0.0038782928966258
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22065,266,0.94 [0.70-1.24],0.6455758334103117
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Viral pneumonia,21238,277,0.94 [0.71-1.25],0.6861875497228707
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22935,236,0.90 [0.66-1.22],0.485224753694951
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10148,114,0.73 [0.46-1.17],0.1906821267066161
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16285,86,1.18 [0.74-1.90],0.4800627495682128
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute appendicitis,23168,140,0.83 [0.55-1.25],0.3657040675805346
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute gastritis,17613,89,0.76 [0.45-1.27],0.294918639009003
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute pancreatitis,21974,197,1.21 [0.88-1.67],0.2323135110613358
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute peritonitis,22954,91,1.05 [0.65-1.71],0.8277266301474872
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22425,109,0.68 [0.42-1.10],0.1135306476950924
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Barrett oesophagus,18039,515,0.70 [0.57-0.87],0.0014959425535134
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21897,120,1.01 [0.66-1.55],0.952899597741116
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22900,120,1.02 [0.67-1.55],0.9373414726269966
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Cholecystitis,21991,214,1.18 [0.86-1.60],0.3012599649791826
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Cholelithiasis,22542,765,0.98 [0.83-1.16],0.8201373105258067
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Chronic gastritis,17789,265,1.00 [0.76-1.33],0.986802073951883
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21835,58,0.87 [0.46-1.65],0.678031142465883
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23101,129,1.04 [0.69-1.55],0.8581545052351929
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Coeliac disease,21716,93,0.99 [0.61-1.61],0.9774538481529595
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Collagenous colitis,21889,48,1.17 [0.61-2.22],0.6336383682160823
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23136,211,1.05 [0.77-1.44],0.7461450669106007
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Constipation,23138,1561,0.96 [0.85-1.08],0.4954157543147806
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Crohn disease,21931,90,1.28 [0.81-2.03],0.2857839902905919
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22961,65,1.19 [0.68-2.06],0.5391763825747904
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21917,76,1.44 [0.89-2.33],0.1366517133379697
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Dental caries,22664,220,0.91 [0.67-1.25],0.575410478959891
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,19715,1894,0.85 [0.76-0.95],0.0034398948838694
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of appendix,23198,170,0.86 [0.60-1.25],0.4329970059519274
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of liver,23159,843,1.04 [0.89-1.22],0.6166876871927951
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21344,3820,0.93 [0.86-1.01],0.0706902036358259
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22942,498,1.00 [0.82-1.23],0.9782802349554832
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23253,390,1.09 [0.87-1.37],0.4679648713113725
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22552,108,0.81 [0.51-1.29],0.3743079954345106
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22417,65,0.78 [0.43-1.42],0.4178903383615788
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22990,1367,0.97 [0.85-1.10],0.6045378979698868
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of tongue,22433,106,1.04 [0.66-1.62],0.8719488648647461
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22941,1164,0.99 [0.86-1.13],0.8488965584565922
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19185,2986,0.96 [0.88-1.04],0.2918637943347481
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Duodenal ulcer,17784,260,1.09 [0.82-1.44],0.5595257341176736
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23184,205,1.10 [0.80-1.51],0.5597949225142942
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23223,47,0.77 [0.38-1.57],0.4712868252634862
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22468,152,1.06 [0.73-1.54],0.7445633586501843
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16372,173,1.01 [0.71-1.43],0.94814432651928
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Functional dyspepsia,17943,419,0.81 [0.64-1.02],0.0703352914307809
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastric ulcer,17883,359,0.87 [0.67-1.11],0.2599200006798811
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19631,2107,0.91 [0.83-1.01],0.0861936200220796
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18109,585,0.96 [0.80-1.17],0.7127627159878913
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,17821,7812,0.93 [0.88-0.98],0.0052126542181353
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,GI-bleeding,22757,1134,0.97 [0.84-1.11],0.6323678632453986
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22488,44,1.28 [0.67-2.44],0.4620920904950715
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17145,1207,0.92 [0.80-1.05],0.1995243354078379
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22398,82,0.97 [0.58-1.62],0.8995274736066752
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Hernia,21293,3472,0.89 [0.82-0.97],0.0057154999969873
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Impacted teeth,23226,44,0.77 [0.37-1.59],0.4732568008998127
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Impaction of intestines,16246,47,1.18 [0.62-2.22],0.6189019534629139
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Inguinal hernia,19433,1612,0.96 [0.85-1.07],0.4490274314370732
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",18010,189,0.97 [0.69-1.37],0.880366646936084
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16284,85,1.37 [0.88-2.14],0.1640579742829729
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21729,106,1.03 [0.66-1.61],0.8890360178675819
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16463,264,0.89 [0.67-1.19],0.4421587386267084
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23254,366,1.07 [0.85-1.36],0.5641289511825057
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22512,671,1.03 [0.86-1.23],0.7787507832132228
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22715,874,0.97 [0.83-1.14],0.7350552371854698
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17734,210,1.01 [0.73-1.38],0.972201034649276
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oesophagitis,18136,612,0.76 [0.63-0.93],0.0062985703931464
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23245,114,0.86 [0.56-1.34],0.5126380574783966
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17898,77,1.13 [0.69-1.87],0.6240844640380663
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17585,1386,0.95 [0.84-1.08],0.4339393751524454
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22030,253,1.06 [0.80-1.42],0.6752535416535342
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21894,117,1.00 [0.65-1.54],0.9884041574142164
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of intestine,18024,1825,0.91 [0.82-1.02],0.1001078134879714
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of intestines,21525,5326,0.93 [0.87-0.99],0.032219636173706
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22395,180,0.93 [0.65-1.31],0.6674800849247711
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of liver,22987,671,1.07 [0.90-1.28],0.4252419781005123
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18239,715,0.80 [0.67-0.96],0.015577308013919
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21916,139,0.92 [0.61-1.38],0.6849919680910761
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23186,323,1.06 [0.83-1.37],0.6261900983585162
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18304,780,0.87 [0.74-1.04],0.1185261740557898
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22769,1146,0.97 [0.84-1.11],0.6257996363381397
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22613,169,1.01 [0.71-1.44],0.9582616168109638
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,17797,1598,0.94 [0.84-1.06],0.3062277482776808
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19329,1805,0.93 [0.84-1.04],0.2112785840739137
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22409,93,0.92 [0.57-1.50],0.7434101936682009
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22606,765,1.02 [0.86-1.20],0.8513035103771963
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16544,345,0.90 [0.70-1.16],0.4340201047942927
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23214,56,0.84 [0.45-1.60],0.6027430719329474
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,16667,468,1.00 [0.81-1.23],0.9811090865025216
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21781,158,0.90 [0.62-1.32],0.5946436058693179
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23286,41,1.03 [0.51-2.10],0.9262561378484298
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22456,105,1.13 [0.73-1.74],0.5877961383254201
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Toxic colitis,21884,43,1.00 [0.49-2.06],0.9921539960435688
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17811,287,0.78 [0.59-1.04],0.0924019031250571
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ulcerative colitis,21987,146,1.13 [0.78-1.64],0.5242613763136226
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21965,124,1.00 [0.65-1.52],0.9828679075130806
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Umbilical hernia,18187,366,0.82 [0.64-1.05],0.1143678655184282
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16353,154,0.96 [0.66-1.39],0.8157508279723299
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ventral hernia,18084,263,0.91 [0.68-1.22],0.5403474090862493
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Volvulus,16270,71,0.87 [0.49-1.53],0.620705584422387
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23225,311,1.09 [0.85-1.42],0.4932132977521983
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,22990,68,0.65 [0.36-1.18],0.1593908231491374
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21340,94,1.11 [0.70-1.76],0.6572844695750681
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22576,728,1.05 [0.88-1.24],0.5986624800229341
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22040,192,0.64 [0.45-0.91],0.0143014255769222
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21706,460,1.00 [0.80-1.24],0.9826271906354168
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23014,269,1.10 [0.83-1.44],0.5110881008500274
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23211,466,0.99 [0.80-1.22],0.9013637296402076
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22790,45,0.99 [0.49-1.98],0.9669270972152112
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21848,3102,0.96 [0.88-1.04],0.2924045370472314
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22860,401,0.88 [0.69-1.11],0.2750328554541037
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22750,291,0.93 [0.71-1.23],0.626810542572886
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22840,992,1.01 [0.87-1.17],0.9102481949510448
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23287,30,1.18 [0.54-2.56],0.6737272350385191
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21267,21,0.82 [0.28-2.39],0.7194831810816495
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22515,56,0.53 [0.27-1.03],0.0617690572920207
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23009,264,1.08 [0.81-1.42],0.6096566616557
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21720,474,0.81 [0.65-1.01],0.0559075744919964
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21323,77,1.35 [0.84-2.17],0.2154287305043951
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23233,79,1.62 [1.05-2.50],0.0282564133119626
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22060,212,1.20 [0.89-1.63],0.2304680208821009
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23130,208,0.92 [0.67-1.28],0.6325219105388561
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22815,70,1.36 [0.82-2.24],0.235985411083974
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21311,65,1.11 [0.64-1.93],0.7118559187698477
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22858,1612,1.00 [0.89-1.12],0.9779090884684168
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21760,514,0.83 [0.68-1.03],0.0939010817617886
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21326,80,1.25 [0.78-2.03],0.3553147343704299
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23211,289,0.83 [0.63-1.10],0.1919809637524681
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22795,50,0.40 [0.19-0.83],0.0145058728663774
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23175,253,0.76 [0.56-1.03],0.0804373184608299
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23244,330,1.03 [0.80-1.33],0.7908237938451759
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21333,87,1.09 [0.67-1.76],0.7411847487047876
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21516,270,0.90 [0.67-1.20],0.4719403537103799
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23238,324,1.04 [0.81-1.35],0.7520534025148464
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21506,260,1.02 [0.77-1.35],0.9022732228739104
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23272,118,1.33 [0.90-1.97],0.1542016148171444
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20113,88,0.70 [0.42-1.18],0.178437871253293
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21259,4685,0.91 [0.85-0.98],0.0077495899706475
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19866,3292,0.84 [0.77-0.91],4.2749957619297234e-05
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20094,69,0.99 [0.57-1.73],0.984499256218172
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20434,148,0.90 [0.61-1.32],0.5875964560256917
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20430,144,1.06 [0.73-1.55],0.755302389061278
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23097,65,0.88 [0.49-1.58],0.67277345264999
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20366,80,1.02 [0.61-1.71],0.9385838611115184
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17425,851,0.78 [0.66-0.92],0.0034639910657784
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23178,142,1.09 [0.74-1.60],0.6676525909942166
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20552,266,0.94 [0.71-1.26],0.6876656921236036
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19827,6135,0.93 [0.88-0.99],0.020934700033037
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22253,88,0.90 [0.54-1.49],0.6845390297822136
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20190,165,1.36 [0.98-1.89],0.067767303607784
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20451,426,0.77 [0.61-0.97],0.0285962509625131
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22490,2204,0.94 [0.85-1.04],0.2223666986509911
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20377,352,0.71 [0.54-0.92],0.0101564841709256
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20077,52,0.83 [0.43-1.61],0.5803873959995636
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20120,95,0.75 [0.45-1.24],0.2632735463470985
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22994,29,1.22 [0.54-2.77],0.630235397813043
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18000,1426,0.83 [0.73-0.94],0.0031137899107183
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,17533,959,1.06 [0.92-1.23],0.4370000402373303
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23160,946,1.11 [0.96-1.29],0.1517603327086983
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16621,47,0.69 [0.34-1.40],0.3000557826165306
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16651,77,0.62 [0.36-1.10],0.1026363785756191
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20288,263,0.81 [0.60-1.09],0.161731404807616
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17185,611,0.86 [0.71-1.05],0.1351262180548576
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20329,43,0.86 [0.42-1.79],0.6939628531171721
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20808,522,1.12 [0.92-1.36],0.264065755805517
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20547,261,0.90 [0.68-1.21],0.5009287906974389
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17146,572,0.85 [0.70-1.04],0.1118463505607093
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20091,66,1.24 [0.72-2.11],0.4361744570409681
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20078,53,1.20 [0.65-2.18],0.5614718571503012
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22258,93,1.20 [0.77-1.89],0.4221563308073259
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23012,847,0.89 [0.76-1.05],0.1789283745686002
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22563,398,0.88 [0.69-1.11],0.2762764971313698
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23215,284,1.15 [0.89-1.50],0.2867600663892394
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18416,1842,0.82 [0.73-0.92],0.000467609727632
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16625,51,0.55 [0.27-1.12],0.1018048626538276
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20107,82,1.23 [0.76-1.98],0.4001174014339872
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16626,52,1.23 [0.68-2.25],0.4933433288617713
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16620,46,0.77 [0.38-1.57],0.4733452606830733
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22344,179,0.95 [0.67-1.34],0.7702701329239902
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22325,160,0.93 [0.64-1.34],0.6848753125967689
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23262,81,0.63 [0.36-1.10],0.1034330741168752
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21788,1502,0.99 [0.88-1.11],0.8216476555484576
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20088,63,0.98 [0.55-1.74],0.9365708838913754
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16614,40,0.53 [0.24-1.17],0.1156788633709068
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20889,603,1.05 [0.87-1.26],0.6091809076257642
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18246,1672,0.85 [0.76-0.96],0.0063724823416203
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23018,53,1.01 [0.53-1.91],0.9803548298003848
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23280,62,0.70 [0.38-1.31],0.2650931300899831
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20104,79,1.18 [0.71-1.95],0.5245614606274698
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20987,962,1.06 [0.91-1.22],0.4715166659132582
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20118,93,1.63 [1.09-2.44],0.0170640564965782
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17761,1187,0.87 [0.76-1.00],0.0543785717376196
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22246,81,0.97 [0.58-1.63],0.9174750246054328
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20067,42,0.68 [0.32-1.46],0.325260987313002
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20395,109,0.93 [0.59-1.45],0.7410252485343995
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20517,492,1.03 [0.84-1.26],0.774251731870054
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23150,185,1.04 [0.74-1.46],0.8085737364474845
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20765,479,1.09 [0.89-1.34],0.3887173650350248
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23224,278,1.16 [0.89-1.51],0.2837455325731436
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23282,37,1.27 [0.62-2.60],0.5124532698203902
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20169,144,0.78 [0.52-1.16],0.2228779707697821
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19098,560,0.83 [0.68-1.02],0.07795417263211
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20489,464,1.09 [0.88-1.34],0.429037922594647
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20342,317,0.65 [0.49-0.87],0.0032132893863579
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16604,30,0.42 [0.17-1.06],0.0673748143659522
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18806,2232,0.96 [0.87-1.06],0.4446131110335075
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,17020,446,0.89 [0.71-1.11],0.294934206967632
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23122,157,1.10 [0.76-1.57],0.621882765672894
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23227,46,0.53 [0.25-1.12],0.0952861398145341
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21362,46,0.63 [0.31-1.30],0.2148528843862224
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16638,64,0.61 [0.33-1.14],0.1193784077566724
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20370,84,0.70 [0.41-1.19],0.1857285840330745
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16866,292,1.08 [0.83-1.41],0.562522350845559
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20295,270,0.62 [0.46-0.84],0.0021331222490923
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20501,215,1.03 [0.76-1.41],0.8437119495109834
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20378,92,0.86 [0.52-1.42],0.5474989764984971
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18490,31,1.30 [0.60-2.81],0.50740394290932
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23283,38,1.28 [0.64-2.60],0.4847272087472049
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20540,515,0.84 [0.68-1.03],0.0977187125588337
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],22983,18,0.52 [0.16-1.71],0.2825363449636726
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22244,2219,0.91 [0.82-1.00],0.0536264146904462
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20127,102,0.49 [0.30-0.81],0.0058172710072108
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20780,494,0.95 [0.77-1.18],0.6614376877740931
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22264,193,0.84 [0.59-1.18],0.3165653710875628
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20409,123,0.83 [0.54-1.28],0.402164190499633
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21579,1293,0.92 [0.81-1.05],0.2281782175513813
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21104,818,0.95 [0.81-1.12],0.555783882722156
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20068,43,1.17 [0.60-2.28],0.6514760097102925
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23003,38,1.35 [0.67-2.74],0.401501491972639
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20142,117,0.69 [0.44-1.09],0.1124457264682622
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20046,21,0.85 [0.56-1.28],0.4408911882169846
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16632,58,0.53 [0.27-1.03],0.0609692510785372
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22315,1831,1.13 [1.02-1.26],0.0227688266434955
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22832,398,1.23 [0.99-1.52],0.0678049754620575
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22572,138,1.23 [0.85-1.79],0.2748507408215587
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22001,1517,1.18 [1.05-1.32],0.0063426084117155
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23052,85,1.53 [0.99-2.37],0.0544381288048543
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23022,346,1.13 [0.89-1.43],0.3222291267061815
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Cystitis,20497,209,0.82 [0.58-1.15],0.2402988778810917
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Dialysis,20588,104,1.33 [0.87-2.03],0.1858113163959175
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22038,3251,0.95 [0.87-1.03],0.202019202154558
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20967,5456,0.99 [0.93-1.06],0.7701556543166683
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23069,102,1.22 [0.79-1.87],0.3711570999112747
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Hydrocele,18994,207,1.01 [0.74-1.39],0.9415562217393162
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,20587,361,1.13 [0.89-1.44],0.3095239870111101
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21339,2552,0.93 [0.84-1.02],0.1131404654373417
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19018,231,1.17 [0.88-1.56],0.2846498259534418
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20364,76,0.67 [0.38-1.19],0.1753811369195898
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,18895,108,0.84 [0.53-1.34],0.466954604666592
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23285,59,0.96 [0.52-1.77],0.9076787145257748
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23289,52,0.74 [0.37-1.48],0.3990404673849697
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22480,2192,0.93 [0.84-1.02],0.1373039537493617
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21219,931,0.98 [0.84-1.15],0.8306840398057472
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23223,547,1.21 [1.00-1.46],0.0470473311326997
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19093,306,0.71 [0.54-0.94],0.0176314093977307
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19068,281,1.02 [0.78-1.35],0.8764008378953254
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19014,227,0.78 [0.57-1.08],0.1359021284132958
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23281,49,0.88 [0.45-1.72],0.7062315428223218
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21774,1486,0.92 [0.81-1.04],0.1604074803222684
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,20628,402,1.13 [0.90-1.42],0.2838103048917285
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22860,184,1.36 [1.00-1.85],0.0535296613786719
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23023,56,1.00 [0.53-1.89],0.9966624114478716
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19047,260,1.04 [0.78-1.38],0.8113925290782913
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23002,2776,1.10 [1.00-1.19],0.041055310578782
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",20299,73,1.51 [0.95-2.42],0.0836884260325161
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,20638,154,1.36 [0.95-1.95],0.0916469434016449
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22511,77,1.40 [0.87-2.24],0.1610083250619714
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20576,288,0.98 [0.74-1.29],0.8700575504108817
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22948,514,1.27 [1.05-1.54],0.0133646402451861
